Smithers Avanza Resource Library

 

Please complete the form below and you will receive a link via email to download this item

 

 

Nonclinical Assessment of NRX-1074, an Orally Bioavailable NMDAR Partial Agonist

Wolfe, G.W., Vegarra, M., Godin, S.G., Houck, D., and Gidda, J.:  Nonclinical Assessment of NRX-1074, an Orally Bioavailable NMDAR Partial Agonist.  Presented at the 53rd Annual Meeting of the Society of Toxicology, Phoenix, Arizona. March 27, 2014.

Featured Publication
Reproductive and Developmental Toxicity Testing

Examination of the Extended One-Generation Reproductive Toxicity Study Guideline
Authors:Shakil A Saghir, Ph.D. and Michael A Dorato, Ph.D.

This whitepaper discusses ways to make the EOGRTS guideline easier to follow; suggesting procedures to select relevant doses, and monitor the systemic exposure at different life stages for better interpretation of the data.